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Optimal activation of human monocytes in vitro for the biosynthesis of tumor necrosis factor was achieved
only with complete S-form lipopolysaccharide. Endotoxin preparations with shorter carbohydrate chains or the
lipid A component of lipopolysaccharide were not able to induce release of comparable amounts of tumor
necrosis factor by monocytes under the conditions described. The same differences in the level of tumor necrosis
factor mRNA were observed. Moreover, addition of these agents to appropriate monocyte-activating
substances inhibited the production of tumor necrosis factor. The regulatory implications of this phenomenon
are discussed.
From numerous investigations, it seemed clear that the
majority of the biological activities exhibited by lipopolysac-
charide (LPS) reside in the lipid A portion of the molecule.
Many of the endotoxic effects of LPS, however, are not
direct effects of this lipid A moiety on the cellular system but
are mediated via induction of biologically active endogenous
factors such as tumor necrosis factor (TNF) or interleukin-1
(IL-1). Among other cells, macrophages and monocytes
produce these factors after activation. TNF is able to induce
all symptoms of endotoxic shock when administered in
recombinant purified form (4, 20). For the production and
secretion of TNF, a two-signal activation process has been
elucidated in the murine macrophage model (18). In this
murine system, it became obvious that LPS alone could
provide all signals required for macrophage activation when
given to cells from LPS-sensitive animals (25). Macrophage
cytotoxicity or TNF release from cells obtained from LPS-
low-responder mice or from high-responder mice, but using
suboptimal amounts of LPS, was induced only after appro-
priate preactivation (first signal). Such preactivation was
conferred in vivo by various bacterial or viral infections or
by a tumor and in vitro by macrophage activation factors
such as gamma interferon (IFN-y). For such prepared mac-
rophages, the lipid A 3-deoxy-D-mannooctulosonic acid
(KDO) molecule of a Re mutant of Salmonella minnesota
was able to function as a second or triggering signal for the
induction of tumor cytotoxicity or TNF release (19). Free
lipid A was also found to induce TNF release into the sera of
presensitized mice in vivo (11).
Human peripheral blood mononuclear leukocytes (PB-
MNL) produced little TNF upon stimulation with LPS
alone. But again, priming with IFN--y before LPS stimulation
greatly augmented TNF release (23). IFN--y activated the
monocytes for tumor cell cytotoxicity, but LPS was required
for the release of TNF from those cells (14). Also, alveolar
macrophages of sarcoidosis patients released TNF upon
stimulation with LPS (1). Thus, LPS seems to act as a
second signal for the induction ofTNF release. In the murine
system, the lipid A part of the LPS molecule was shown to
be the structure required for this TNF release.
LPS is also a very good inducer of IL-1 activity from
* Corresponding author.
human peripheral mononuclear cells. Loppnow and co-
workers demonstrated that for IL-1 release, the presence of
3-acyloxyacyl residues on the lipid A moiety of LPS were
essential under the conditions used (17). Another group
determined the heptosyl-(1, 5)-KDO disaccharide of the LPS
molecule as the minimal structure required for IL-1 release
from human monocytes (16).
In this study, we tested several LPS preparations of S- and
R-form mutants and lipid A for the ability to induce TNF and
IL-1 in human PBMNL, in the adherent fraction of human
PBMNL, and in THP-1 cells. We found that optimal release
of TNF and IL-1 from PBMNL from monocytes obtained
from healthy blood donors and from THP-1 cells was in-
duced only with the complete S-form LPS molecules. Short-
ening of the polysaccharide chain of LPS led to reduced IL-1
release. LPS R forms and lipid A induced only small
amounts of IL-lot and TNF mRNAs compared with the
amounts produced by optimally stimulated cells. When the
same agents were added to cultures of monocytes stimulated
with other activating agents, they were inhibitory.
MATERIALS AND METHODS
Reagents. LPS preparations consisted of LPS from Salmo-
nella montevideo SH94 prepared by the phenol-water ex-
traction method, followed by the phenol-chloroform petrol
ether procedure (9). LPS of Salmonella abortus-equi H1178,
LPS of S. minnesota H907 (R7 preparation), LPS of S.
minnesota H306 (R595 preparation), and lipid A from Esch-
erichia coli (AcP [acetate buffer] preparation) were all gen-
erously supplied by H. Brade in solutions of 1 mg/ml in
phosphate-buffered saline (PBS). All preparations had been
converted to the uniform triethylamine and sodium salt
forms, respectively, by electrodialysis and neutralized by
the respective bases (8). Clear nonopalescent solutions were
obtained. The protein content of the S. abortus-equi LPS
was <0.2%, and that of R595 and lipid A was <0.5%, as
determined by amino acid analysis. The DNA content of all
preparations was <0.2%. Corresponding portions of the
same batches as the preparations used for this study had
biological activities (e.g., direct toxicity, galactosamine tox-
icity, Schwartzman and pyrogen activity, and B-cell mitoge-
nicity) in other test systems. Glutaraldehyde-fixed Staphy-
lococcus aiureus cells (Pansorbin; Calbiochem-Behring, La
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Jolla, Calif.) were used as a 0.1% (wt/vol) suspension.
Recombinant human IFN--y (rhIFN-y) (specific activity, 2 x
107 U/mg) was provided by G. R. Adolf, Ernst Boehringer
Institut fur Arzneimittelforschung. Phorbol 12-myristate 13-
acetate (PMA) was purchased from Sigma Chemical Co.,
Deisenhofen, Federal Republic of Germany.
Culture medium. The culture medium used was RPMI
1640 (GIBCO Laboratories, Grand Island, N.Y.) with 10%
heat-inactivated fetal calf serum (GIBCO) and gentamicin
(50 p.g/ml; Sigma) unless stated otherwise.
Preparation of cells. Human PBMNL were prepared from
buffy coats of healthy blood donors by Ficoll-Hypaque
density gradient centrifugation (3). For preparation of the
adherent cell fractions, the cells (3 x 106/ml) were seeded in
24-well plastic Falcon tissue culture plates (Becton Dickin-
son Labware, Oxnard, Calif.) and incubated for 2 h at 37°C
in a humid atmosphere containing 5% CO2. Nonadherent
cells were removed by washing the cultures three times with
culture medium. The remaining cell fraction consisted of
>90% monocytes, as determined by morphology and phago-
cytosis. Cells of the human leukemic cell line THP-1 (26)
were cultured in the manner described for human PBMNL.
TNF assay systems. The cytotoxicity assay for TNF was
carried out on sensitive L929 mouse fibrosarcoma cells (2 x
104 cells per 0.2 ml of culture) in the presence of actinomycin
D (2 pg/ml; Sigma). The cultures contained serial dilutions of
TNF samples. After 20 h of culture, the surviving cells were
fixed and stained with crystal violet (0.5% crystal violet, 3%
[vol/vol] formaldehyde, 0.17% NaCl, 22.3% ethanol) for 15
min. Excess dye was washed off with water, and the
remaining dye was solubilized in 33% acetic acid. A540 was
measured. Concentrations of TNF are expressed as titers
indicating the reciprocal dilution of the samples in triplicate
at which 50% survival was measured. Sensitivity of this
assay varied between 1 and 0.5 ng of rhTNF per ml. Titers
below 8 were considered background.
TNF activity was also measured by an enzyme-linked
immunosorbent assay (ELISA). For ELISA, 96-well flat-
bottom plates (Titertek; Flow Laboratories, Meckenheim,
Federal Republic of Germany) were coated with affinity-
purified (protein A-Diasorb; Diagen, Dusseldorf, Federal
Republic of Germany) polyclonal rabbit anti-recombinant
human TNF antibodies (5 jig/ml in 0.05 M NaHCO3 buffer[pH 9]) for 16 h at 4°C. Serial dilutions of the test samples in
0.1 M phosphate buffer (2% EDTA-1% bovine serum albu-
min [pH 7.5]) were applied to the plates for 2 h at room
temperature after blocking with 1% bovine serum albumin in
PBS for 2 h at room temperature. Plates were washed with
PBS containing 0.05% Tween, and biotin (Sigma)-conjugated
affinity-purified (protein A-Diasorb) polyspecific rabbit anti-
rhTNF antibodies (2.7 pg/ml) were added to the wells for 1.5
h at room temperature. After extensive washing with PBS
containing 0.05% Tween, a 1:2,000 dilution of streptavidin-
peroxidase complex (Bethesda Research Laboratories, Inc.,
Karlsruhe, Federal Republic of Germany) was applied for 30
min at room temperature. The plates were washed again with
PBS containing 0.05% Tween, and the substrate solution
(3,3',5,5'-tetramethylbenzidine [Miles Scientific, Munich,
Federal Republic of Germany], 10 mg in 100 ml of 0.1 M
sodium acetate-citric acid buffer [pH 4.9], and 14.7 ,ul of 30%
H202) was added to the complex. The reaction was stopped
with 2 M H2SO4, and A450 was measured. The absorption
curves obtained with the test samples were compared
against a standard curve obtained with rhTNF, and TNF
content was expressed as nanograms per milliliter. The
sensitivity of this TNF assay was 0.5 ng of rhTNF per ml.
IL-1 assay system. IL-1 activity was determined by the
conventional costimulator assay. In brief, single-cell suspen-
sions of C3H/HeJ thymocytes (5 x 105 per culture) were
cultured in the presence of phytohemagglutinin (PHA-M; 50
p.g/ml; Sigma) and serial dilutions of the test samples for 3
days. The cultures were pulsed with 1 ,uCi of tritiated
thymidine ([6-3H]thymidine; specific activity, 50 Ci/mmol
[185 GBq/mmol]; Amersham Buchler, Braunschweig, Fed-
eral Republic of Germany) for 6 h, and incorporated counts
were determined. IL-1 titers are given as the final dilutions of
the supernatants in triplicate that gave counts per minute
2.5-fold higher than background.
RNA extraction and dot blot analyses. The procedure used
has been described in detail recently (5). Cells (105 to 106 per
culture) were solubilized with 1 ml of 7.6 M guanidine
hydrochloride in 0.1 M potassium acetate buffer (pH 5), and
DNA was sheared by aspiration five times through a 21-
gauge needle. A 0.6-ml amount of 95% ethanol was admixed,
and RNA was precipitated at -20°C for 12 h. RNA was
pelleted by 20 min of centrifugation at 15,000 x g, the pellet
was dissolved in 150 pL1 of 15% formaldehyde in water, and
150 .1I of 20x SSC (SSC is 0.15 M sodium chloride plus 0.015
M sodium citrate) was added. The solution was heated for 15
min at 50°C and chilled on ice. Equal portions or serial
dilutions were applied to nylon filters (Compas; Genofit,
Heidelberg, Federal Republic of Germany) prewetted with
water and 1Ox SSC. The RNA was fixed on the nylon filters
by exposure to UV light for 2 min, and hybridization was
performed as described in detail by Khandjian (13) at 42°C in
the presence of dextran sulfate. The filters were washed
twice under high-stringency conditions (65°C, 30 min, 2x
SSC containing 1% sodium dodecyl sulfate). Probes were
labeled with [32P]GTP and [32P]CTP (specific activity, 3,000
Ci/mmol; Amersham, Frankfurt, Federal Republic of Ger-
many) by the random-primer method, using a hexamer
(Pharmacia, Freiburg, Federal Republic of Germany).
The TNF cDNA probe, a 425-base-pair PstI fragment of
the nontranslated 3' region of human TNF, was obtained
from BASF (Ludwigshafen, Federal Republic of Germany).
The IL-lot and IL-13 probes, gifts of U. Gubler (Hoffmann-
La Roche Inc., Nutley, N.J.), consisted of a 460-base-pair
human IL-1 EcoRI-BamHI cDNA fragment [p3(ILlot)] and a
530-base-pair human IL-1 BamHI-NdeI cDNA fragment
[pll(IL1l)], respectively, of the coding region. The human
,B-actin cDNA probe, described by Moos and Gallwitz (21),
consists of a 560-base-pair SalI-EcoRI cDNA fragment.
RESULTS
PBMNL from normal blood donors were stimulated with
complete S-form LPS preparations from S. montevideo and
S. abortus-equii, with LPS from a rough mutant of S.
minnesota (R7), with LPS from a Re mutant of S. minnesota
(R595), consisting of the lipid A part with one KDO residue
attached, and with purified lipid A from E. coli. After 16 h,
cell-free supernatants from these cultures were tested in the
biological assay for TNF activity (Table 1). Cultures were
stimulated with Staphylococcius aureus as a positive control,
which led to strong cytotoxic TNF activity in the superna-
tant. Only complete S-form LPS induced release of high
levels of TNF activity. LPS from S. montevideo was a better
inducer than S. abortus-equii LPS. The R7, R595, and lipid A
preparations did not induce measurable TNF release even at
the highest concentrations tested. Addition of IFN--y to the
culture in combination with S. abortus-eqiui LPS induced
higher TNF titers than did LPS stimulation alone but again
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TABLE 1. Release of cytotoxic activity by PBMNL
after stimulation in vitro"
StimulatngatConcn TN F titerStimulating agent Cocn
___g__________(,ug/ml) - IFN-y + IFN-y
None 4
Salnonella nlontcvidc(eo LPS 10 25
1 8
0.1 6
(.01 6
0.001 4
Staphylococceus tairleis 10 64
1 12
Saimnonellti abortius-eqii LPS 10 8 25
1 6 12
0.1 6 6
R7 10 2 2
1 2 3
0.1 2 4
R595 10 4 3
1 2 4
0.1 4 2
Lipid A 10 3 2
1 3 3
0.1 3 4
PBMNL (3 x 106/ml) were stimulated for 16 h with the indicated
preparations in the presence or absence of IFN-y (100 U/ml). The cytotoxic
activity in the supernatants was determined in the biological TNF assay.
cells(104)
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did not lead to release of measurable TNF activity when
given together with R7, R595, or lipid A. No inhibitory
substance was released after stimulation with R7, R595, or
lipid A, as determined in the biological test system in which
a defined amount ofTNF was mixed with these supernatants
and tested for activity (data not shown).
The same pattern of TNF activity was obtained when the
adherent cell fraction (>90% monocytes) was stimulated
with different substances (Table 2). Again, only LPS from S.
montevideo and S. aborttis-eqimi released significant cyto-
toxic activity into the supernatant. Taken together, these
data indicate that only S-form LPS was able to induce
significant TNF production in monocytes.
Cells used for the experiment shown in Table 2 were
probed for the presence of TNF mRNA to test whether only
the release of TNF protein or also the expression of TNF
mRNA was dependent on the complete S-form LPS as
inducer. RNA from the cells was extracted and blotted on
TABLE 2. Release of cytotoxic activity by the adherent cell
fraction of PBMNL after stimulation in vitro"
Stimulating agent Concn (,ug/ml) TNF titer
Salmnonella montevideo LPS 1 32
0.001 32
Salmnonella aIbortiis-eqUi LPS 1 16
0.001 4
R7 1 4
0.001 8
R595 1 4
0.001 4
Lipid A 1 4
0.001 4
None 4
Staphy2lo(-o((cus aiiureis 1 32
" The adherent cell fraction of 3 x 10' PBMNL per ml was stimulated for
16 h with the indicated preparations. The cytotoxic activity in the superna-
tants was determined in the biological TNF assay.
5 -.
2.5
FIG. 1. TNF, IL-cx, IL-11, and ,B-actin mRNA expression in
adherent PBMNL after stimulation with different agents. Dilutions
of mRNA from 2 x 105 adherent PBMNL stimulated with LPS from
S. lnontevideo, S. tabortius-eqiui (Sae). R7. R595, or Staphylococcus
aureus (1 FLg/ml or 1 ng/ml. as indicated) or unstimulated were
extracted after 2 h and blotted onto a nylon filter. The filter was
hybridized consecutively with cDNA probes for TN F, I L-1.( I L-1,B.
and ,3-actin and autoradiographed.
nylon filters in different concentrations. After hybridization
with a TNF cDNA probe, it was obvious that LPS from S.
abortius-equi induced a much higher signal than did the R7,
R595, or lipid A preparation (Fig. 1). Thus, also at the level
of mRNA expression, complete S-form LPS was required
for optimal induction.
After hybridization of the same filter with an IL-iot cDNA
probe, optimal IL-iot mRNA signals were again induced by
S-form LPS (Fig. 1). On the other hand, when the same filter
was probed with an IL-13 cDNA probe, the strongest signal
was again obtained after stimulation with complete S-form
LPS, but RNA of cells stimulated with R7, R595, and lipid A
also showed positive signals. The amounts of RNA of all
samples were comparable, as can be seen by the intensities
of the dots after hybridization with 3-actin cDNA. TNF
mRNA expression was maximal 2 h after stimulation with
Staphylococcis aiureius or S-form LPS. To investigate
whether the kinetics ofTNF mRNA expression were shifted
by using R7, R595, or lipid A, TNF mRNA was monitored
up to 20 h after stimulation. No significant induction of TNF
mRNA was detected (data not shown).
When the monocytelike tumor cell line THP-1 was stimu-
lated. a similar pattern of results was obtained. Cytotoxic
activity was detected only in supernatants of cells stimulated
with complete S-form LPS (Table 3). Also, IL-1 activity was
found in supernatants of THP-1 cells (Table 3). Unstimulated
cells produced some IL-1 activity, but highest values were
VOL. 57. 1989
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TABLE 3. Release of IL-1 activity, cytotoxic activity, and
TNF by THP-1 cells after stimulation"
TNF
Stimulating agent Concn IL-1 titer"
Titer" (ng/ml)"
None <2 <0.5 8
Salmonella minnesota LPS 64 2.5 64
Salmonella abortuts-eqli LPS 12 1.0 128
R7 <2 <0.5 16
R595 <2 <0.5 16
Lipid A <2 <0.5 8
S. minnesota LPS
+ S. abortus-equi LPS 12 1.0 64
+ R7 3 <0.5 16
+ R595 3 <0.5 4
+ Lipid A 3 <0.5 8
THP-1 cells (106/ml) were stimulated for 16 h with the indicated prepara-
tions (10 ,ug/ml each).
' Determined in supernatants in the corresponding biological assay sys-
tems.
' Determined by ELISA.
obtained in supernatants of cells stimulated with LPS from
S. minnesota or S. abortus-equi. To exclude the possibility
that the cytotoxic effect measured in the supernatants re-
sulted from the increased IL-1 levels rather than TNF
secretion, the supernatants were also tested in the TNF-
specific ELISA system. Significant amounts were detected
only in supernatants of THP-1 cells stimulated with S.
minnesota or S. abortuls-equi LPS and thus correlated with
the cytotoxic activity.
Furthermore, stimulation of monocytes with R7, R595,
and lipid A together with LPS from S. minnesota abrogated
the appearance of measurable TNF in the supernatants of
those cells and reduced the levels of secreted IL-1 activity
(Table 3). Thus, R7, R595, and lipid A were not inactive
preparations but were capable of inhibiting the activation of
LPS-induced TNF release.
The same inhibition of release of TNF activity by R7,
R595, and lipid A into the supernatant of THP-1 cells was
observed when the cells were stimulated with PMA instead
of LPS (Table 4). Other functions of these cells were not
inhibited. Trypan blue exclusion, conversion of the tetra-
zolium salt MTT (22), and uptake of Staphylococcus aureus
U)
-J
cells e
(104) X
10
5
5,
Cl)
a): n X Uc DN.L) CZ~ 2r-61) CL
Cl
A
t-
TABLE 4. Release of cytotoxic activity by THP-1
cells after stimulation"
Stimulating agent TNF titer
Salmonella minnesota LPS........................................ 48
+ Salmonella abortiUs-eqCfi LPS .............................. 16
+ R7 ............................................ <2
+ R595 ............................................ <2
+ LipidA ............................................ <2
PMA ............................................ 48
+ S. abortus-equi LPS .......................................... 48
+ R7 ............................................ 12
+ R595 ............................................ <2
+ LipidA ............................................ <2
" THP-1 cells (106/ml) were stimulated for 16 h with the indicated agents.
The endotoxin preparations were used in concentrations of 10 ,ug/ml; PMA
was used at 10 ng/ml. Cytotoxic activity in the supernatants was determined
in the biological TNF assay.
were the same as in untreated cells or cells treated with
complete S-form LPS (data not shown).
The same results were obtained at the TNF mRNA level in
THP-1 cells. Only LPS from S. minnesota, LPS from S.
abortus-eqiui, PMA, and Staphylococcus aiureus induced
significant signals (Fig. 2). R7-, R595-, and lipid A-stimulated
THP-1 cells showed only background signals, but these
agents reduced the intensity of the TNF mRNA specific
signal when added to either S. minnesota LPS, Staphyloc oc-
cuis aureus, or PMA during stimulation. The same amounts
ofRNA had been blotted onto the filters, as can be seen from
the results of hybridization with a P-actin cDNA probe.
DISCUSSION
This study shows that as in the murine system, in human
PBMNL cultures complete S-form LPS is the favored agent
to induce both the production and release of TNF. Although
the sensitivities of cells from different donors varied consid-
erably, in all experiments performed only the complete
S-form LPS molecule induced high levels of TNF release
and TNF mRNA expression over the background level of
unstimulated cells when used in microgram amounts per
milliliter. Incomplete R-form LPS and the lipid A part of the
molecule were not effective inducers of TNF production in
this system. As shown in Table 1 and in accordance with
S. min. LPS + Staph. a. + PMA +
Cl) (1) C/)
0. 0.
0) <Cla a a) 1)a)0
Cs _ CC) co .2- co ,) Q
CC Ir -X c a: [ -J u) r CC X
X , . a *
* , * 6 W.
cDNA probe
TNF
2.5
10 * * * 0 v * q * *0 0 * * *0 *O 9
5 , 0 *000** 0 0* * * a @ * * * * 0
2.5 > o ..* 4ce
0 ki B-Actin
FIG. 2. TNF and P-actin mRNA expression in THP-1 cells after stimulation with different agents and combinations thereof. Dilutions of
mRNA from 105 THP-1 cells stimulated with S. abortuts-eqiui (Sae) LPS, R7, R595, lipid A, LPS from S. minnesota, or Staphylococcus aureus
(10 p.g/ml each), PMA (10 ng/ml), or combinations of these agents as indicated were extracted after 2 h and blotted onto a nylon filter. The
filter was hybridized consecutively with a TNF cDNA probe and a P-actin cDNA probe and autoradiographed.
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previously published findings (23), the simultaneous activa-
tion of monocytes by LPS and IFN--y led to higher TNF
titers but was not able to restore the activity of the incom-
plete LPS preparations. A similar difference in effectiveness
of complete LPS versus lipid A has recently been reported
for studies in which TNF production induced in vitro was
compared in a murine system (15). One could argue that the
polysaccharide part of endotoxin carries distinct immuno-
modulatory activities (7) or that physicochemical properties
of the endotoxin preparations influence the biological activ-
ity. Therefore, it is possible that the incomplete forms of the
endotoxins did not convey all of the necessary signals.
Addition of IFN-y did not provide the missing signal.
It is conceivable that culture conditions or cell preparation
procedures used for the experiments described here contrib-
uted to the differences in activities of the endotoxin prepa-
rations. Most important, the presence of 10% fetal calf
serum in all media could interfere with the potency of the
activating agents. Therefore, all experiments were repeated
in serum-free culture medium. The results obtained in these
experiments were qualitatively identical to those described
above. The general difference was a higher amount of TNF
protein as well as stronger TNF mRNA signals.
In several cases, high levels of IL-1 and TNF production
without prior in vitro stimulation were observed. It is
possible that this was due to preactivation of the blood cells
of the individual donors. These cells were not used for
further experiments. Except for the experiments shown in
Fig. 1 and Table 2, which were performed with the same
cells, all experiments were carried out with cells from
different donors. All experiments were repeated at least
three times with cells from different blood donors. The
monocytic leukemia cell line THP-1 showed the same reac-
tivities toward the different endotoxin preparations. This
finding is in full accordance with the recent observation by
Russmann et al., who found that complete S-form LPS
molecules were necessary for TNF release from THP-1 cells
(E. Russmann, personal communication).
On the molecular level, Beutler and colleagues found that
in cells of LPS-low-responder animals or dexamethasone-
treated cells, a posttranscriptional blockade inhibited the
release of mature TNF molecules; however, a partial tran-
scriptional blockade was also found (2). In the murine
system, it was found that LPS was responsible for the
release of TNF from activated macrophages (19). The data
presented here show, in addition, that mRNA levels of TNF
are also regulated by LPS.
With respect to IL-1 production, the results for IL-la and
IL-1lB and for TNF appear to be very similar. The require-
ments seem not to be as stringent for the production of
IL-1a. Since soluble IL-1 measured in the supernatant
consists mainly of IL-lp (12), reports determining parts of
the lipid A structure essential for IL-1 release (15, 16) are not
contradictory to our results.
It was surprising to find that substances such as the R7,
R595, and lipid A preparations and, in some cases, the
relatively less potent S. abortus-equi LPS (Tables 3 and 4)
actively inhibited TNF production and TNF mRNA expres-
sion of monocytes that were stimulated with potent TNF
inducers. Similar observations were reported by others.
Ding and Nathan reported that after exposure to trace levels
of LPS, mouse peritoneal macrophages were refractory for a
respiratory burst response (6). Possible mechanisms for such
antagonizing effects, e.g., receptor blockage, receptor down-
regulation, or cyclooxygenase product formation, have been
considered. Furthermore, Proctor et al. reported that mice
were protected against lethal endotoxemia by a monosac-
charide precursor of lipid A, lipid X (24). Several lines of
evidence point to inhibition by lipid X of toxic mediator
release from effector cells (10). It remains open to specula-
tion whether such a phenomenon could be part of a regula-
tory mechanism.
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